Skip to main content
Premium Trial:

Request an Annual Quote

One Codex, Transnetyx Collaborate on Microbiome Sequencing and Analysis Services

NEW YORK – One Codex and Transnetyx said on Wednesday they will be jointly offering end-to-end microbiome sequencing and analysis services for human and mouse samples.

"Through this partnership, Transnetyx and One Codex can offer researchers fully automated DNA extraction, library preparation, and sequencing with faster turnaround times and a lower price than ever before," One Codex CEO Nick Greenfield said in a statement. "Sequencing results will be uploaded and analyzed automatically on One Codex for a seamless experience."

Financial and other details of the deal were not disclosed.

Based in Memphis, Tennessee, Transnetyx offers genotyping services, including detecting transgenic mutations, SNPs, and CRISPR-mediated mutations in animal research models. Thompson Street Capital acquired the company as part of a 2018 deal to buy YX Genomics Holding.

Founded in 2014, One Codex offers a bioinformatics platform for microbial genomics. It launched an end-to-end microbiome sequencing and analysis service in November 2020. In 2017, the firm partnered with ATCC on microbiome research tools.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.